The Best of Times, the Worst of Times

Abstract

The recent tragic death of a young gene therapy patient has marred the field of gene therapy research. Yet, as Anderson explains in a Perspective, encouraging new results from a study in which a severe immunodeficiency disease is corrected in two infants by delivery of the defective gene ( Cavazzana-Calvo et al.) have brought cautious optimism back to the gene therapy field.